-
EP4516782
European procedure
- EP About this file
- EP Legal status
- EP Federated register
- EP Event history
- EP Citations
- EP Patent family
- EP All documents
Extract from the Register of European Patents
EP About this file: EP4516782
| EP4516782 - CRYSTAL FORM OF BLARCAMESINE HYDROCHLORIDE, METHOD FOR PREPARING SAME, AND USE THEREOF [Right-click to bookmark this link] | Status | Examination is in progress Status updated on 30.01.2026 Database last updated on 09.04.2026 | |
| Former | Request for examination was made Status updated on 31.01.2025 | ||
| Former | The international publication has been made Status updated on 03.11.2023 | Most recent event Tooltip | 18.03.2026 | New entry: Renewal fee paid | Applicant(s) | For all designated states Crystal Pharmaceutical (Suzhou) Co., Ltd. B4-301 Biobay 218 Xinghu Street Suzhou Industrial Park Suzhou, Jiangsu 215123 / CN | For all designated states Moehs Iberica SL Pol Ind Rubi Sud César Martinell i Brunet 12a 08191 Rubi, Barcelona / ES | [2025/10] | Inventor(s) | 01 /
ZHANG, Yuxing Suzhou, Jiangsu 215123 / CN | 02 /
ZHU, Hongyan Suzhou, Jiangsu 215123 / CN | 03 /
MENG, Liping Suzhou, Jiangsu 215123 / CN | [2025/10] | Representative(s) | dompatent Partnerschaft von Patentanwälten und Rechtsanwälten mbB Deichmannhaus am Dom Bahnhofsvorplatz 1 50667 Köln / DE | [N/P] |
| Former [2025/10] | dompatent von Kreisler Selting Werner - Partnerschaft von Patent- und Rechtsanwälten mbB Deichmannhaus am Dom Bahnhofsvorplatz 1 50667 Köln / DE | Application number, filing date | 23795565.3 | 27.04.2023 | [2025/10] | WO2023CN91293 | Priority number, date | CN202210472873 | 29.04.2022 Original published format: CN202210472873 | CN202210473993 | 29.04.2022 Original published format: CN202210473993 | CN202210623900 | 02.06.2022 Original published format: CN202210623900 | [2025/10] | Filing language | ZH | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO2023208133 | Date: | 02.11.2023 | Language: | ZH | [2023/44] | Type: | A1 Application with search report | No.: | EP4516782 | Date: | 05.03.2025 | Language: | EN | [2025/10] | Search report(s) | International search report - published on: | CN | 02.11.2023 | (Supplementary) European search report - dispatched on: | EP | 13.05.2025 | Classification | IPC: | C07D307/14, A61K31/341, A61P25/28 | [2025/10] | CPC: |
C07D307/14 (EP,US);
A61K31/341 (EP,US);
A61K9/2013 (EP,US);
A61K9/2027 (EP,US);
A61K9/2054 (EP,US);
A61P25/28 (EP);
C07C59/245 (EP,US);
C07C59/255 (EP,US);
C07C59/265 (EP,US);
C07B2200/13 (EP,US)
(-)
| Designated contracting states | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, ME, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2025/10] | Title | German: | KRISTALLFORM VON BLARCAMESINHYDROCHLORID, VERFAHREN ZU IHRER HERSTELLUNG UND VERWENDUNG DAVON | [2025/10] | English: | CRYSTAL FORM OF BLARCAMESINE HYDROCHLORIDE, METHOD FOR PREPARING SAME, AND USE THEREOF | [2025/10] | French: | FORME CRISTALLINE DE CHLORHYDRATE DE BLARCAMÉSINE, SON PROCÉDÉ DE PRÉPARATION ET SON UTILISATION | [2025/10] | Entry into regional phase | 28.11.2024 | Translation filed | 28.11.2024 | National basic fee paid | 28.11.2024 | Search fee paid | 28.11.2024 | Designation fee(s) paid | 28.11.2024 | Examination fee paid | Examination procedure | 28.11.2024 | Examination requested [2025/10] | 05.11.2025 | Amendment by applicant (claims and/or description) | 05.11.2025 | Date on which the examining division has become responsible | 02.02.2026 | Despatch of a communication from the examining division (Time limit: M04) | Fees paid | Renewal fee | 25.02.2025 | Renewal fee patent year 03 | 17.03.2026 | Renewal fee patent year 04 |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Documents cited: | Search | [DI] WO2021158586 (TEVA PHARMACEUTICALS INT GMBH et al.) [DI] 1-14 * Whole document, particularly example 10, page 35; page 35; example 10 * | [DA] WO2019200345 (ANAVEX LIFE SCIENCES CORP et al.) [DA] 1-14 * whole document, particularly pages 12-20, crystal forms I-VII.; page 12 - page 20 * | [A] MINO R CAIRA ED - MONTCHAMP JEAN-LUC: "CRYSTALLINE POLYMORPHISM OF ORGANIC COMPOUNDS", TOPICS IN CURRENT CHEMISTRY; [TOPICS IN CURRENT CHEMISTRY], SPRINGER, BERLIN, DE, vol. 198, 1 January 1998 (1998-01-01), pages 163 - 208, XP001156954, ISSN: 0340-1022, [retrieved on 19990226], DOI: 10.1007/3-540-69178-2_5 [A] 1-14 * page 165 - page 180 * DOI: http://dx.doi.org/10.1007/3-540-69178-2_5 | International search | [X] WO2021158586 (TEVA PHARMACEUTICALS INT GMBH et al.) [X] 1-22 * description, page 35, paragraph [00201], and description, figure 13 * | [A] CN108026059 (ANAVEX LIFE SCIENCES CORP et al.) [A] 1-22 * entire document * | [A] CN112105349 (ANAVEX LIFE SCIENCES CORP et al.) [A] 1-22 * entire document * | by applicant | WO2021158586 | WO2017013498 | WO2019200345 |